Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Predicting Language and Literacy Growth in Children With ASD Using Statistical Learning
NCT06332144 · View on ClinicalTrials.gov ↗
Study Summary
The goal of this observational study is to test a reciprocal relationship between statistical learning and the development of language and literacy in first-graders with autism and their non-autistic peers. The main questions it aims to answer are: 1. whether children's statistical learning abilities can predict their long-term improvement of language and literacy skills in school; 2. how children's brains automatically learn patterns from speech and prints; 3. whether children's learning in the lab reflects the language patterns they have learned over the years from their native language. First-grade students will participate in the study twice across three months. During Time 1, children will complete * a battery of language, reading, and cognitive assessments * a series of computer-based statistical learning games both inside and outside of functional MRI scanner. During Time 2, children will complete a battery of language and reading assessments to detect the growth in three months. Researchers will compare the autistic and the non-autistic groups to see if statistical learning plays a similar or different role in predicting children's language and literacy growth.
Conditions Studied
Interventions
- BEHAVIORAL Structural vs. Random sequences of stimuli
- BEHAVIORAL Intact vs. Degraded speech
- BEHAVIORAL Repeating 5-syllable nonwords or 2-syllable nonwords
- BEHAVIORAL Recall letter or syllable strings that either contain highly frequent bigram/trigram items or infrequent items according to English Corpus data.
Study Locations (2)
Massachusetts
- Northeastern University — Boston
- Boston University — Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2024-01-13 |
| Est. Completion | 2025-08-31 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06332144
The ClinicalTrials.gov registry entry for NCT06332144 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northeastern University, which has 108 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 3 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 4 interventions — of which Structural vs. Random sequences of stimuli is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT06332144 reports 2 study locations spanning 1 distinct geographic area — top geographies include Massachusetts. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT06332144 about?
NCT06332144 is a clinical study titled "Predicting Language and Literacy Growth in Children With ASD Using Statistical Learning". The goal of this observational study is to test a reciprocal relationship between statistical learning and the development of language and literacy in first-graders with autism and their non-autistic peers. The main questions it aims to answer are: 1. whether children's statistical learning abiliti...
What is the current status of trial NCT06332144?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2024-01-13. Estimated completion is 2025-08-31.
What conditions does trial NCT06332144 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Language Development, Literacy. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT06332144?
The interventions under investigation include: Structural vs. Random sequences of stimuli (BEHAVIORAL), Intact vs. Degraded speech (BEHAVIORAL), Repeating 5-syllable nonwords or 2-syllable nonwords (BEHAVIORAL), Recall letter or syllable strings that either contain highly frequent bigram/trigram items or infrequent items according to English Corpus data. (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT06332144?
This trial is sponsored by Northeastern University, which has 108 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT06332144 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.